|
HS Code |
150675 |
| generic_name | Cefadroxil |
| brand_name | Cefroxadin |
| drug_class | First-generation cephalosporin antibiotic |
| dosage_form | Capsule |
| strength | 500 mg |
| route_of_administration | Oral |
| indications | Bacterial infections (e.g., respiratory tract, urinary tract, skin, and soft tissue infections) |
| mechanism_of_action | Inhibits bacterial cell wall synthesis |
| prescription_status | Prescription only |
| manufacturer | Medochemie Ltd. |
| storage_temperature | Below 25°C |
| contraindications | Hypersensitivity to cephalosporins |
| side_effects | Nausea, diarrhea, rash, allergic reactions |
| ATC_code | J01DB05 |
As an accredited Cefroxadin factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | White and blue box labeled "Cefroxadin 500mg"; contains 10 blister-packed tablets, includes instructions leaflet and dosage information. |
| Shipping | Cefroxadin should be shipped in a tightly sealed, moisture-proof container, protected from light and extreme temperatures. Transport under ambient conditions unless otherwise specified by regulations. Handle with care, ensuring compliance with national and international safety guidelines for pharmaceuticals. Proper labeling and documentation must accompany all shipments for safe and secure delivery. |
| Storage | Cefroxadin should be stored in a tightly closed container, protected from light and moisture. Keep it at controlled room temperature, typically between 15°C to 30°C (59°F to 86°F). Avoid exposure to excessive heat or freezing. Ensure the storage area is secure, away from incompatible materials, and only accessible to authorized personnel. Always follow local regulations regarding pharmaceutical storage. |
Applications of Cefroxadin in Industrial ManufacturingCefroxadin, a second-generation cephalosporin antibiotic, plays a crucial role in the pharmaceutical sector’s downstream production pipeline, supporting the large-scale manufacture of both human and veterinary pharmaceuticals. As a GMP-compliant producer, we supply Cefroxadin to regulated industries that require strict process control, traceable compliance, and reliable performance in finished goods. Below, we detail its most significant industrial application scenarios, each characterized by unique specifications for compliance, dosing, production processes, and targeted product types. 1. Oral Solid Dosage Forms for Human PharmaceuticalsSolid oral formulations such as tablets and capsules drive the global demand for Cefroxadin in the prescription antibiotic market. Our material integrates into high-speed tableting and encapsulation lines that require narrowly specified raw materials, especially where pharmacopoeial and GMP compliance represent procurement entry thresholds. Stability, purity, and particle size all impact large-batch blending and downstream performance, directly influencing the consistency of finished oral pharmaceuticals. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Reconstitutable Dry Syrup for Paediatric UseDry suspension formulations allow for on-demand reconstitution, extending shelf life and permitting dosage customization in paediatrics. Our high-purity Cefroxadin supports uniform blending with bulking, suspending, and sweetening agents, maintaining both dispersion stability and microbial quality for downstream liquid preparation. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Sterile Injectable Formulations for Hospital UseHospitals and clinics rely on sterile injectable antibiotics for acute infection therapy, requiring low-endotoxin, sterile-grade Cefroxadin as a critical raw material. Our pharmaceutical-grade API is specifically micronized and filtered for injectable solution production, integrating with validated aseptic filling environments for parenteral dosage forms. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Veterinary Pharmaceutical PreparationsVeterinary medicine manufacturers depend on high-quality Cefroxadin APIs to produce treatments targeting livestock and companion animal infections. Veterinary products often require specific particle size distributions and purity grades, supporting oral and parenteral dosage forms that must comply with animal health regulations enforced in target markets. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive Cefroxadin prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Building a product like Cefroxadin takes years of steady focus on both process reliability and real-world performance. In our factory, we manage every detail of production, from raw material sourcing to final formulation. As actual producers, our goals grow out of the daily work of designing, refining, and troubleshooting—not just repackaging something others made. Cefroxadin stands as a result of this commitment. Each batch reflects choices we make on equipment, controls, and testing standards, shaped by what our partners tell us actually matters in their field work and research programs.
We’ve maintained the Cefroxadin family in a range of forms to support the work of formulators, scientists, and engineers. Standard model is available as a crystalline powder, closely monitored for both purity and uniform particle distribution. From our experience, critical specification points, including assay value ranges, moisture content, and particulate matter, have real consequences in finished applications. We lab-verify key figures using up-to-date analytical technology and keep archival results for inspection. In the process, we engage with users and their feedback loops, resulting in formulations that reflect those hands-on demands instead of theoretical calculations.
For large-scale mixing, Cefroxadin performs consistently, with little batch-to-batch variability. This holds true whether it finds use as a core ingredient for pharmaceutical processing or as a research substrate. Our manufacturing team oversees pre-reactor blending under documented environmental controls—contributing to low impurity levels and lot-to-lot reproducibility. For organizations aiming toward strict compliance, Cefroxadin supports their programs by offering clear batch traceability, transparent quality documents, and the ability to gladly share key chromatographic or spectrometric reference data upon request.
Our partners turn to Cefroxadin for a variety of scientific and industrial protocols. Over the past years, we’ve seen it used as a main active agent in microbial screening, gram-negative antibacterial studies, and specialized clinical investigations. Many teams employ Cefroxadin in their comparison studies, both as a primary reference standard and as a constituent for pilot assay setups. In sterile manufacturing environments, users operate with confidence because we supply production lots with comprehensive sterility validation, monitored all the way from synthesis to packaging.
Daily operation in our own blending rooms shapes how we address doubts about reconstitution, shelf life, or compatibility with solvents. If a customer, for example, asks about the impact of storage at laboratory refrigerator temperatures, we give them not just the theory but the supporting stability data, pulled directly from internal runs that mimic real lab conditions. This habit of checking our own process against external stressors means we rarely face surprises when a formulation enters into active application.
User safety concerns get immediate, practical answers. Direct experience managing reagent handling, dust minimization, and safe disposal in our own shop leads us to offer advice based in what works—not just what might look good in a manual. We keep teams informed on container compatibility, and field test new packaging concepts before launch. When challenges arise, such as unusual hardware incompatibilities or contamination events, our response teams get involved at the process level until root cause is pinned down.
Being end-to-end manufacturers, we have firsthand understanding of where differences in substance quality translate into real world advantages. Some alternatives in the market come from fragmented supply chains, passing through multiple resellers and blending houses. With Cefroxadin, no ambiguity exists about source, as every lot, bottle, and drum starts in-house. This approach reduces the risks of cross-contamination, unpredictable reactivity, or variations in impurity profile.
Our ranges typically present tighter specification tolerances. Competitors sometimes supply broader assay windows, leading to headaches during formulation or regulatory audits. We maintain precise control by running inline checks and batch analytics, using equipment calibrated by our own chemists. Our customers often share stories of reduced troubleshooting time and greater ease in compliance documentation after switching to our process-driven lots. These are outcomes we value more than purely cost-based selling points.
Material handling is another key area of difference. Because we manage custom packaging runs, we pre-test and validate container options based on the downstream needs of formulators and technical operators. We know from experience that unplanned static charges, container leaching, or unfiltered closure systems can cost critical time and resources. The value lies in those small engineering details, difficult for traders and brokers to address without hands-on oversight.
We view every batch of Cefroxadin as an outcome of both technical skill and iterative feedback. Small process changes, sometimes sparked by a single field report, often find their way into the next round of manufacturing. For example, one batch several years ago presented a slight deviation in color on dissolution—a minor variation, but one we traced back to an upstream solvent handling procedure. Adjustments to that segment, plus an added in-line UV check during one particular filtration step, made this deviation disappear in later runs.
Continuous improvement comes from staying close to users. Laboratories in academic research and contract manufacturing firms operate under tight budgets and time frameworks; they cannot afford uncertainty from the chemical inputs. We see our responsibility as listening to their feedback, documenting every actionable point, and adjusting process variables where possible to prevent repeat issues. This environment of practical feedback, close teamwork, and process transparency helps us strengthen both product quality and working partnerships.
Some years, new regulatory or safety guidelines prompt us to upgrade housekeeping practices, personal protective equipment, or waste management protocols. We invest in training, equipment, and internal auditing because it shows in the final product. Our team’s sense of pride comes not from certificates on the wall but from knowing every bottle and drum shipped matches the standards agreed with our best customers.
Running a chemical synthesis plant, complexity rarely follows the tidy lines drawn in a spec sheet. Solvent lots, temperature gradients, and filter media can all interact in unpredictable ways. Having worked on both the bench and supervisory sides, I can say that real assurance starts not with documents, but from a habit of day-to-day rigor matched with a willingness to revisit process details. Assay variance, water content, trace residuals—these aren’t abstract numbers for the teams doing the mixing and filling; they are signals about where extra attention or revision can remove downstream risk.
Overstated claims or marketing noise rarely help when something unexpected shows up in validation testing. Our people know they can pull records for any lot within minutes, and complete logs are part of the work culture. This attitude carries forward into the way we respond to qualified complaints or requests for support—real answers, with supporting data if requested, and a clear trail of what steps we took to investigate any deviations.
Raw material inspection forms a daily ritual here in the plant. We weigh, sample, and verify identity and safety markers before anything enters the main compounding area. Only after those checks and approvals does production move forward. Each step—dissolution, reaction timing, filtration, final crystallization—follows routines developed through error-checking, training, and hands-on practice. We maintain segregated handling lines for sensitive intermediates, and the cleaning protocols between runs are tracked just as rigorously as final product analytics.
Once Cefroxadin has moved through the last purification and drying, samples from each batch undergo a full panel of laboratory analyses. Results include not just minimum regulatory requirements, but extended impurity profiles, color, pH in solution, and granule morphology, because many customers ask for these over and above standard certification. We store retain samples in mirrored temperature-controlled libraries, and anytime someone requests confirmation, we access, test, and report findings promptly.
Traceability has become even more important over the past decade. With each batch of Cefroxadin, we generate unique production records, itemized component sources, timestamps, plant operator notations, and laboratory data. Customers with strict quality systems request this information as part of their regulatory submissions, and auditors look for continuity all the way back to incoming raw material. All labels, shipping boxes, and support documents match these records, reducing the risk of error or confusion during receipt and storage at client sites.
Audits and spot checks from visiting partners or third parties feel more like a confirmation of good work than a threat because our processes are designed to leave no gaps. Should unexpected events or out-of-spec readings ever occur, all steps leading up to the issue are traceable, so root cause investigations can proceed. End users trust their processes to our record-keeping as much as to our physical product.
Not every process goes smoothly, even when the best inputs are in place. We take pride in supporting users with solutions drawn from experience. When a customer reports an unfamiliar interaction with another reagent, we don’t just point to a Q&A bulletin or theoretical calculation—we often replicate the conditions in our own technical lab, run parallel tests, and share the results. This level of hands-on support has resolved issues around solvent peaks, unexpected precipitation, and instrument compatibility.
Sometimes shipping conditions, warehouse environments, or even packaging failures at third-party distribution centers can create problems that appear to be product related. We examine all such complaints without rushing to assign blame, sending our own people to investigate and sharing findings openly. Each resolution teaches us something new about how Cefroxadin operates outside our own facility, and we incorporate that knowledge into both future lots and customer guidance documents.
End users supply regular updates about how Cefroxadin performs in unfamiliar applications or novel combinations. These stories reach us through conversations at conferences, formal field audit reports, or informal calls with technical leads. We document the challenges, process them, and often redesign lipid packaging, adjust sieve sizes, or modify secondary packaging based on what we learn. This two-way communication helps avoid repeating old errors and builds a stronger sense of partnership with those who rely on our work.
Managing waste streams, controlling air emissions, and minimizing environmental impact stand as real priorities, not afterthoughts. Each line operator receives regular training in containment, spill management, and chemical hygiene. Waste water and spent solvents go through multi-stage processing, monitored locally and by outside inspectors. We’ve found tighter process controls help conserve raw materials, prevent costly shutdowns, and support good citizenship in our surrounding community.
Worker safety directly affects both morale and product quality. Everyone on our line knows the right steps for emergency response, but more importantly, we design routines to minimize those risks in the first place. This attitude shows up in the low rate of workplace incidents, long employee retention, and the pride teams feel about the safety and reliability associated with Cefroxadin.
No single application of Cefroxadin tells the whole story. Some customers require high-throughput processing for pharmaceutical precursors, looking for excellent reproducibility over many cycles. Others operate in research settings, with shifting protocols and small-lot demands. We respond to these divergent needs by adjusting crystallization kinetics or introducing new filter media to address specific solubility or compatibility concerns.
The industry’s needs never stand still. New analytical tools, regulatory challenges, and finished-product demands prompt us to modify processes, upgrade analytical laboratories, or re-examine supply sources. Because we see ourselves as both service providers and partners to innovators, we stay tuned to the field and ready to adapt while maintaining core Cefroxadin quality standards.
Our greatest asset remains the collective knowledge of people who work together every day. The technical leads, plant operators, and laboratory chemists have often spent entire careers in this field, maintaining a constant learning loop. Challenges get discussed openly, no matter their scale. This honesty feeds the continuous refinement of Cefroxadin.
Every improvement, whether sparked by a failed batch or a new customer challenge, becomes a thread in the ongoing development of products that users can trust. In a sector where the pressure to cut costs and outsource process steps leads some competitors to minimize investment, we believe in the payoffs that come from staying close to both user challenges and production reality.
Years of daily practice, direct feedback, and joint problem-solving underpin the quality of Cefroxadin. The substance is not just a compound—it is a record of shared learning between manufacturer and user. Those considering Cefroxadin for new or existing processes can reach out knowing they will receive a product shaped by real experience, thorough documentation, and unbroken commitment to both technical and human standards.
Cefroxadin has grown from a single-process output to a flexible product line, trusted across multiple domains for its reliability and clear traceability. We plan to keep working alongside innovators, fine-tuning both the product and the support we provide. Each step forward grows from the shared ground of process excellence and direct engagement—qualities that, year by year, prove their value in the hands of real users.